OAM
CRVS icon

Oxford Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Oxford Asset Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$73K Sell
34,709
-125,064
-78% -$508K 0.01% 158
2019
Q4 		$869K Buy
159,773
+36,064
+29% +$126K 0.02% 949
2019
Q3 		$372K Buy
123,709
+29,013
+31% +$122K 0.01% 1375
2019
Q2 		$354K Buy
94,696
+6,663
+8% +$26.1K 0.01% 1407
2019
Q1 		$354K Sell
88,033
-4,568
-5% -$19.3K 0.01% 1365
2018
Q4 		$340K Buy
92,601
+28,665
+45% +$195K 0.01% 1350
2018
Q3 		$550K Buy
63,936
+8,902
+16% +$89K 0.01% 1282
2018
Q2 		$607K Buy
55,034
+1,682
+3% +$18.8K 0.01% 1265
2018
Q1 		$615K Buy
53,352
+29,523
+124% +$279K 0.01% 1159
2017
Q4 		$256K Buy
+23,829
New +$305K 0.01% 1381
2017
Q2 		– Sell
-13,809
Closed -$287K – 1508
2017
Q1 		$287K Buy
+13,809
New +$216K 0.01% 1210

Other funds holding CRVS

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return